Alpha Wealth Funds’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alpha Wealth Funds’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$730K	Sell	4,612 -957	-17%	-$129K	0.4%	23
2026 Q1	$711K	Sell	5,569 -324	-5%	-$40.4K	0.48%	16
2025 Q4	$719K	Sell	5,893 -218	-4%	-$25K	0.44%	19
2025 Q3	$612K	Sell	6,111 -2,250	-27%	-$203K	0.45%	20
2025 Q2	$693K	Sell	8,361 -439	-5%	-$35K	0.58%	21
2025 Q1	$714K	Sell	8,800 -7,209	-45%	-$644K	0.72%	23
2024 Q4	$1.44M	Buy	+16,009	New	+$1.55M	1.39%	14

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Alpha Wealth Funds's XBI Position: Q2 2026 in Review

Alpha Wealth Funds reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q2 2026, selling an estimated $129K and leaving 4,612 shares worth $730K. The position accounts for 0.4% of the portfolio, ranked #23.

Alpha Wealth Funds first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.44M in Q4 2024. 929 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Alpha Wealth Funds held 4,612 shares of State Street SPDR S&P Biotech ETF worth $730K as of Q2 2026.
Alpha Wealth Funds sold 957 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $129K.
State Street SPDR S&P Biotech ETF made up 0.4% of Alpha Wealth Funds's portfolio in Q2 2026, its #23 holding.
Alpha Wealth Funds first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
Alpha Wealth Funds's State Street SPDR S&P Biotech ETF position peaked at $1.44M in Q4 2024.
929 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Alpha Wealth Funds's 13F filing for Q2 2026, filed 11 Aug 2026.